In this study, patients with esophageal or gastric cancer will be treated with topoisomerase-1inhibitory compounds and the relevant tumor parameters that may predict tumor response to therapy will be investigated. The lab was used for PCR and ELISA analysis.
Showing the most recent 10 out of 470 publications